Round table - The role of biopharmaceutical tools in Quality by Design

Monday 14th of April 2014
RT03, 1.5 hours

Chair: Jennifer Dressman (Germany)

Room: Meeting room 210

16.00 – 16.40      The role of biopharmaceutics toolls in Quality by Design
(MO-25-01) Jennifer Dressman, Goethe University, Frankfurt, Germany

16.40 – 17.00     Horses for Courses: Picking the right biopharmaceutics tool for QbD in the indutrial setting
(MO-25-03) Bertil Abrahamsson, Astra Zeneca, Wilmington, USA

17.00 – 17.30     The Biopharmaceutics Risk Assessment Roadmap (BioRAM): Building in clinical relevance for patient benefit
(MO-25-04) Arzu Selen, FDA's Office of New Drug Quality Assessment, USA

Q & A